China probing AstraZeneca employees for potential illegal acts

AstraZeneca has confirmed that several of its employees in China are under investigation for potential illegal data collection and unapproved drug imports. The probes, led by Shenzhen authorities, involve five current and former Chinese employees. AstraZeneca has not provided further details. China remains a crucial market for the pharmaceutical giant.